-
2022-501176-26-00
5
2023-08-04
Acute Ischemic Stroke and High-Risk Transient Ischemic Attack
-
2022-501939-16-00
5
2023-05-09
Heart failure (HF) with mildly reduced ejection fraction (HFmrEF) or H
-
2022-501744-15-00
5
2023-01-23
Obesity, Overweight
-
2023-505974-14-00
5
2022-06-23
Multiple Sclerosis (MS)
-
2024-516315-24-00
5
2022-05-27
myopia
-
2023-507795-51-00
5
2022-05-17
atherosclerotic heart and blood vessel disease (the narrowing of arter
-
2024-510735-21-00
5
2021-11-26
Atherosclerotic cardiovascular disease (ASCVD)
-
2023-508292-37-00
5
2020-03-06
Cardiovascular Disease
-
2023-506827-26-00
5
2019-05-02
While it is well-established that long-term good glycaemic control wil
-
2023-510298-33-00
4
2016-11-29
Prostate Cancer
-
2024-510640-32-00
5
2024-10-16
Stage IV Non-squamous non-small cell lung cancer
-
2024-511665-11-00
6
2024-08-29
Neovascular age-related macular degeneration (nAMD)
-
2023-508736-62-00
4
2024-08-08
Heart failure (HF) with reduced ejection fraction (HFrEF)
-
2023-509412-28-00
4
2024-07-26
Type 2 Diabetes
-
2023-507459-31-03
5
2024-05-22
wet macula degeneration
-
2023-503333-22-00
5
2024-01-15
Moderate to severe controlled asthma according to Step 4 and Step 5 of
-
2022-501418-69-00
5
2023-11-21
Acute Coronary Syndrome
-
2022-502833-25-00
5
2023-08-02
Obesity
-
2023-503794-38-00
5
2022-11-24
Prevention of stroke or systemic embolism in atrial fibrillation
-
2023-508571-37-00
4
2022-04-29
Geographic atrophy (GA) secondary to Age-related Macular Degeneration
-
2024-512880-30-00
5
2021-08-27
Neovascular Age-related Macular Degeneration (wet AMD)
-
2023-505786-88-00
5
2021-04-25
Severe and inadequately controlled asthma
-
2023-507846-96-00
5
2020-06-19
Type 2 Diabetes Mellitus
-
2023-506487-13-00
5
Hormone receptor-positive, her2-negative advanced/metastatic breast ca